Aimei Health Technology Co. Ltd. has extended its business combination deadline by one month, from February 6, 2026, to March 6, 2026, by depositing an extension payment of $34,330.96 into its trust account for public shareholders. To fund this extension, the company issued an unsecured promissory note totaling $34,330.96 to its sponsor, Aimei Health Ltd., and United Hydrogen Group Inc., who each contributed $17,165.48. The promissory note bears no interest and is payable upon completion of the company’s business combination with United Hydrogen. The payees may choose to convert the note, wholly or partially, into private units of Aimei Health Technology at $10.00 per unit immediately before the business combination closes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimei Health Technology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-006694), on February 13, 2026, and is solely responsible for the information contained therein.